These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31145286)

  • 1. CD4+CD25+Foxp3+ regulatory T cells suppress NKG2D-mediated NK cell cytotoxicity in peripheral blood.
    Geng X; Li M; Cui B; Lu C; Liu X; Zhang P; Liu B; Ma C; Shen Y; Lu Z
    Medicine (Baltimore); 2019 May; 98(22):e15722. PubMed ID: 31145286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmented anti-tumor activity of NK-92 cells expressing chimeric receptors of TGF-βR II and NKG2D.
    Wang Z; Guo L; Song Y; Zhang Y; Lin D; Hu B; Mei Y; Sandikin D; Liu H
    Cancer Immunol Immunother; 2017 Apr; 66(4):537-548. PubMed ID: 28184969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK cells lyse T regulatory cells that expand in response to an intracellular pathogen.
    Roy S; Barnes PF; Garg A; Wu S; Cosman D; Vankayalapati R
    J Immunol; 2008 Feb; 180(3):1729-36. PubMed ID: 18209070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
    Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
    J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-18 synergism with interleukin-2 in cytotoxicity and NKG2D expression of human natural killer cells.
    Qi YY; Lu C; Ju Y; Wang ZE; Li YT; Shen YJ; Lu ZM
    Asian Pac J Cancer Prev; 2014; 15(18):7857-61. PubMed ID: 25292077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+CD25+ Regulatory T Cells Inhibit Natural Killer Cell Hepatocytotoxicity of Hepatitis B Virus Transgenic Mice via Membrane-Bound TGF-β and OX40.
    Chen Y; Sun R; Wu X; Cheng M; Wei H; Tian Z
    J Innate Immun; 2016; 8(1):30-42. PubMed ID: 26067079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-2/IL-18 prevent the down-modulation of NKG2D by TGF-beta in NK cells via the c-Jun N-terminal kinase (JNK) pathway.
    Song H; Hur DY; Kim KE; Park H; Kim T; Kim CW; Bang S; Cho DH
    Cell Immunol; 2006 Jul; 242(1):39-45. PubMed ID: 17070508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-30c promotes natural killer cell cytotoxicity via up-regulating the expression level of NKG2D.
    Ma Y; Gong J; Liu Y; Guo W; Jin B; Wang X; Chen L
    Life Sci; 2016 Apr; 151():174-181. PubMed ID: 26968781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma.
    Cox ST; Danby R; Hernandez D; Laza-Briviesca R; Pearson H; Madrigal JA; Saudemont A
    Front Immunol; 2018; 9():1282. PubMed ID: 29963042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients.
    Mirjačić Martinović K; Babović N; Džodić R; Jurišić V; Matković S; Konjević G
    J Transl Med; 2015 Apr; 13():120. PubMed ID: 25889680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer.
    Smyth MJ; Teng MW; Swann J; Kyparissoudis K; Godfrey DI; Hayakawa Y
    J Immunol; 2006 Feb; 176(3):1582-7. PubMed ID: 16424187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foxp3-transduced polyclonal regulatory T cells suppress NK cell functions in a TGF-beta dependent manner.
    Zhou H; Chen L; You Y; Zou L; Zou P
    Autoimmunity; 2010 Jun; 43(4):299-307. PubMed ID: 20166879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
    J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cord blood CD4
    Liu A; Wang Q; Yang X; Shen S; Xu Y
    Front Biosci (Landmark Ed); 2019 Jun; 24(7):1259-1270. PubMed ID: 31136978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral Foxp3+ regulatory T cells and natural killer group 2, member D expression levels in natural killer cells of patients with colorectal cancer.
    Shen Y; Wang Q; Qi Y; Cui B; Zhang Z; Su J; Liu X; Lu C; Ye H; Ju Y; Lu Z
    Mol Med Rep; 2014 Aug; 10(2):977-82. PubMed ID: 24819058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
    Guo KY; Mei JZ; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis.
    Guo SW; Du Y; Liu X
    Hum Reprod; 2016 Jul; 31(7):1462-74. PubMed ID: 27130956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human tumor-induced and naturally occurring Treg cells differentially affect NK cells activated by either IL-2 or target cells.
    Bergmann C; Wild CA; Narwan M; Lotfi R; Lang S; Brandau S
    Eur J Immunol; 2011 Dec; 41(12):3564-73. PubMed ID: 21905023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced interaction between natural killer cells and lung cancer cells: involvement in gefitinib-mediated immunoregulation.
    He S; Yin T; Li D; Gao X; Wan Y; Ma X; Ye T; Guo F; Sun J; Lin Z; Wang Y
    J Transl Med; 2013 Aug; 11():186. PubMed ID: 23937717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.
    Konjević G; Mirjačić Martinović K; Vuletić A; Babović N
    Melanoma Res; 2010 Dec; 20(6):459-67. PubMed ID: 20938360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.